Today, Oregon Public Employees Retirement Fund decides to keep it stake in CVS Health Corporation (CVS) to the level of $10,037,000

Today, Oregon Public Employees Retirement Fund decides to keep it stake in CVS Health Corporation (CVS) to the level of $10,037,000

Oregon Public Employees Retirement Fund decreased its stake in shares of CVS Health Corporation (NYSE:CVS) by 54.9% during the third quarter, according to its most recent disclosure with the SEC. The firm owned 112,793 shares of the pharmacy operator’s stock after selling 137,401 shares during the period. Oregon Public Employees Retirement Fund’s holdings in CVS Health Corporation were worth $10,037,000 as of its most recent filing with the SEC.

A number of other hedge funds have also made changes to their positions in CVS. Acrospire Investment Management LLC raised its position in CVS Health Corporation by 542.2% in the second quarter. Acrospire Investment Management LLC now owns 1,066 shares of the pharmacy operator’s stock valued at $102,000 after buying an additional 900 shares during the period. Springbok Capital Management LLC raised its position in CVS Health Corporation by 190.5% in the first quarter. Springbok Capital Management LLC now owns 1,130 shares of the pharmacy operator’s stock valued at $117,000 after buying an additional 741 shares during the period. Pinkerton Retirement Specialists LLC raised its position in CVS Health Corporation by 3,475.0% in the second quarter. Pinkerton Retirement Specialists LLC now owns 1,144 shares of the pharmacy operator’s stock valued at $110,000 after buying an additional 1,112 shares during the period. MU Investments Co. Ltd. raised its position in CVS Health Corporation by 62.0% in the second quarter. MU Investments Co. Ltd. now owns 1,150 shares of the pharmacy operator’s stock valued at $109,000 after buying an additional 440 shares during the period. Finally, D Orazio & Associates Inc. raised its position in CVS Health Corporation by 9.4% in the second quarter. D Orazio & Associates Inc. now owns 1,160 shares of the pharmacy operator’s stock valued at $111,000 after buying an additional 100 shares during the period. Institutional investors and hedge funds own 80.44% of the company’s stock.

CVS Health Corporation (NYSE:CVS) traded up 0.97% on Monday, reaching $74.78. 8,577,219 shares of the company’s stock were exchanged. CVS Health Corporation has a 1-year low of $69.30 and a 1-year high of $106.67. The company has a 50 day moving average price of $81.80 and a 200-day moving average price of $91.85. The company has a market capitalization of $79.75 billion, a PE ratio of 16.03 and a beta of 0.88.

CVS Health Corporation (NYSE:CVS) last posted its quarterly earnings data on Tuesday, November 8th. The pharmacy operator reported $1.64 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.57 by $0.07. CVS Health Corporation had a return on equity of 17.18% and a net margin of 2.96%. The company had revenue of $44.60 billion for the quarter, compared to the consensus estimate of $45.29 billion. During the same period in the previous year, the business earned $1.28 EPS. CVS Health Corporation’s revenue for the quarter was up 15.5% compared to the same quarter last year. On average, equities research analysts anticipate that CVS Health Corporation will post $5.81 earnings per share for the current year.

The company also recently declared a quarterly dividend, which was paid on Thursday, November 3rd. Stockholders of record on Monday, October 24th were issued a $0.425 dividend. The ex-dividend date was Thursday, October 20th. This represents a $1.70 dividend on an annualized basis and a dividend yield of 2.28%. CVS Health Corporation’s dividend payout ratio (DPR) is 36.40%.

Several equities research analysts recently commented on CVS shares. Leerink Swann reissued a “buy” rating and issued a $105.00 price target on shares of CVS Health Corporation in a report on Wednesday, November 9th. Morgan Stanley reissued a “hold” rating and issued a $104.00 price target on shares of CVS Health Corporation in a report on Monday, September 12th. Deutsche Bank AG reissued a “hold” rating and issued a $99.00 price target (down previously from $108.00) on shares of CVS Health Corporation in a report on Tuesday, October 18th. Guggenheim reissued a “buy” rating and issued a $90.00 price target (down previously from $115.00) on shares of CVS Health Corporation in a report on Tuesday, November 8th. Finally, Argus reissued a “buy” rating and issued a $85.00 price target (down previously from $120.00) on shares of CVS Health Corporation in a report on Thursday, November 10th. Five analysts have rated the stock with a hold rating, thirteen have issued a buy rating and one has given a strong buy rating to the company’s stock. The company has an average rating of “Buy” and an average target price of $106.24.

About CVS Health Corporation

CVS Health Corporation, together with its subsidiaries (CVS Health), is a pharmacy company. The Company operates through three business segments: Pharmacy Services, Retail/LTC and Corporate. The Company offers a range of products and services, such as advising patients on their medications at its CVS Pharmacy locations, introducing programs to help control costs for its clients at CVS Caremark, how care is delivered to its patients with conditions through CVS Specialty, pharmacy care for the senior community through Omnicare.

Related posts

Leave a Comment